Immunol Allergy Clin North Am. 2008 Nov;28(4):779-802, viii.

Subcutaneous administration of IgG.

Source

Department of Pediatrics, Case Western Reserve University, Cleveland, OH, USA. melvin.berger@uhhospitals.org

Abstract

The availability of IgG preparations that could be administered safely by the intravenous route was finally achieved in the early to mid-1980s. Intravenous immunoglobulin (IVIG) revolutionized the treatment of primary immune deficiency diseases (PIDD) and led to the discovery of the therapeutic value of high-dose IgG in autoimmune and inflammatory diseases not associated with PIDD. Improved therapy has improved outcomes and expectations, and most PIDD patients can lead fully active and productive lives. Administration of IgG by the subcutaneous route is effective and safe and overcomes obstacles to the use of IVIG in some patients. Many patients find administration of subcutaneous IgG at home more convenient than receiving IVIG at the Doctor's office or hospital. The coming years will see increased use of subcutaneous immunoglobulin in PIDD, which will be facilitated by advances leading to higher-concentration IgG products and easier delivery.

PMID:: 18940574; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Save items

Related citations in PubMed

Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home. [J Clin Immunol. 2006]
Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home.
Nicolay U, Kiessling P, Berger M, Gupta S, Yel L, Roifman CM, Gardulf A, Eichmann F, Haag S, Massion C, et al. J Clin Immunol. 2006 Jan; 26(1):65-72.
Review Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose. [Curr Opin Allergy Clin Immunol...]
Review Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose.
Berger M. Curr Opin Allergy Clin Immunol. 2011 Dec; 11(6):532-8.
Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases. [Postgrad Med. 2011]
Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases.
Stein MR, Koterba A, Rodden L, Berger M. Postgrad Med. 2011 Sep; 123(5):186-93.
[Subcutaneous immunoglobulin substitution and therapy]. [Orv Hetil. 2011]
[Subcutaneous immunoglobulin substitution and therapy].
Gulácsy V, Maródi L. Orv Hetil. 2011 Jan 9; 152(2):64-7.
Review Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route. [BioDrugs. 2007]
Review Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route.
Gardulf A. BioDrugs. 2007; 21(2):105-16.

See reviews... See all...

Cited by 4 PubMed Central articles

Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency disease. [Clin Exp Immunol. 2010]
Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency disease.
Wasserman RL, Irani AM, Tracy J, Tsoukas C, Stark D, Levy R, Chen J, Sorrells S, Roberts R, Gupta S. Clin Exp Immunol. 2010 Sep; 161(3):518-26.
Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency. [J Clin Immunol. 2010]
Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency.
Hagan JB, Fasano MB, Spector S, Wasserman RL, Melamed I, Rojavin MA, Zenker O, Orange JS. J Clin Immunol. 2010 Sep; 30(5):734-45. Epub 2010 May 8.
Review How I treat common variable immune deficiency. [Blood. 2010]
Review How I treat common variable immune deficiency.
Cunningham-Rundles C. Blood. 2010 Jul 8; 116(1):7-15. Epub 2010 Mar 23.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Subcutaneous administration of IgG.
Subcutaneous administration of IgG.
Immunol Allergy Clin North Am. 2008 Nov ;28(4):779-802, viii.

PubMed
Efficacy and safety of coadministration of ezetimibe and simvastatin in adolesce...
Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia.
J Am Coll Cardiol. 2008 Oct 21 ;52(17):1421-9.

PubMed
Statistical treatment of withdrawal in trials of anti-dementia drugs.
Statistical treatment of withdrawal in trials of anti-dementia drugs.
Lancet. 2008 Oct 18 ;372(9647):1382-3; author reply 1383.

PubMed
The use of simulation technology in the education of nursing students.
The use of simulation technology in the education of nursing students.
Nurs Clin North Am. 2008 Dec ;43(4):593-603, vii.

PubMed
Can evidence change belief? Reported mobile phone sensitivity following individu...
Can evidence change belief? Reported mobile phone sensitivity following individual feedback of an inability to discriminate active from sham signals.
J Psychosom Res. 2008 Nov ;65(5):453-60. Epub 2008 Aug 15 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Subcutaneous administration of IgG.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information